Clinical Evidence Results from the Hairgenetix 150-day clinical trial and published peer-reviewed research The Hairgenetix clinical trial In a 150-day clinical trial involving 30 men and women aged 1865 with various types of hair loss, the Hairgenetix serum achieved: 93% reduction in hair shedding (pull test) 75% of participants reported visible new growth by day 90 70% improvement in hair density (trichoscopy) 90% satisfaction rate at trial completion All participants used the Meso-Infusion System as directed, with assessments at 30, 60, 90, 120, and 150 days under medical supervision
Many patients achieve excellent results with minimal or no nausea when dose escalation matches their individual tolerance
Alcohol and the risk of sleep apnoea: a systematic review and meta-analysis
Take 2 tablets (1000mg) daily, preferably with a meal, for maximum benefits
How tirzepatide reduces liver fat The mechanism involves multiple pathways working simultaneously
It is supplied as 1200 mg per vial, with 10 vials per box